Sotorasib User Reviews & Ratings
Brand names: Lumakras
Sotorasib has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Non Small Cell Lung Cancer | 1 reviews for Non Small Cell Lung Cancer | 69 medications |
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about sotorasib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Non Small Cell Lung Cancer "I am very fortunate as I have only been taking Lumakras for 12 weeks and have shown positive results already. In my 1st CT scan since starting the drug, my cancer cells have remained the same, some have shrunk in size, and some have disappeared. My prescription is to take 3 pills of 320mg each in the morning."